EMD Serono
BAVENCIO
Manufacturer:
EMD Serono
Name:
BAVENCIO
HCPCS Code Descriptor:
Injection, avelumab, 10 mg
Category:
J Code
HCPCS:
J9023
NDC(s):
44087-3535-01
Primary Type:
Oncology
Generic/Specialty Status:
Single-Source
Route of Administration:
Intravenous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
BAVENCIO is an Oncology drug manufactured by EMD Serono and administered via the Intravenous route of administration. The J Code: J9023 is aligned to the drug BAVENCIO.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/18
HCPCS Effective Date:
1/1/18
HCPCS Short Description:
Injection, avelumab, 10 mg
Billing and Coding Guide:
https://www.coverone.com/content/dam/web/health-care/biopharma/web/CoverOne/Documents/HH1118213-02-D10-BAUS-CoverOne_CCP_Guide_2020_CLU-Digital.pdf
Patient Assistance:
https://www.coverone.com/en/home.html